Collection: Pronacera Therapeutics

Pronacera Therapeutics is a biotechnology company focused on the development of genetic diagnostic tools and treatments for pathologies in different medical areas such as reproduction, fibromyalgia and rare diseases or those with diagnostic gaps, with the aim of helping to optimize health systems through improvements in diagnostic times and methods.

Among the many R&D lines currently being developed, the reproductive genomics and endometrial functional molecular biology line stands out. Specifically, it develops the design of markers and performs genetic analysis of infertility focused on female endometrial tissue. It emerged as a spin-off from the Physiology, Anatomy, and Cell Biology group at Pablo de Olavide University, whose origins date back to 2011.